Clinuvel Pharmaceuticals Stock
Clinuvel Pharmaceuticals Stock
A loss of -2.550% shows a downward development for Clinuvel Pharmaceuticals.
For the coming years our community has positive and negative things to say abot the Clinuvel Pharmaceuticals stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Customer and product portfolio" there were negative voices in the community.
Pros and Cons of Clinuvel Pharmaceuticals in the next few years
Pros
?
B****
?
M***** P*******
?
S********** s********
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Clinuvel Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Clinuvel Pharmaceuticals | -2.550% | 0.036% | -11.685% | -5.545% | -22.123% | -56.159% | -70.672% |
| Carbylan Therapeutics Inc | -1.220% | -5.814% | 10.204% | 60.396% | 27.559% | 121.918% | -22.857% |
| Pharma Mar S.A. | 0.710% | 1.979% | 18.078% | 26.105% | 23.256% | 125.121% | 1.189% |
| Mayne Pharma Group Ltd. | -2.500% | 1.667% | -6.870% | -67.380% | -24.691% | -50.407% | 376.563% |
